SNGX

Soligenix, Inc.

4.77 USD
+0.62 (+14.94%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Soligenix, Inc. stock is down -18.04% since 30 days ago. The next earnings date is Aug 19, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 7 June’s closed higher than May.

About Soligenix, Inc.

Soligenix, Inc. focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions.